Partial Oral versus Intravenous Antibiotic Treatment of Endocarditis
Author(s) -
Kasper Iversen,
Nikolaj Ihlemann,
Sabine Gill,
Trine Madsen,
Hanne Elming,
Kaare Jensen,
Niels Eske Bruun,
Dan Eik Høfsten,
Kurt Fursted,
Jens Jørgen Christensen,
Martin Schultz,
Christine Falk Klein,
Emil Loldrup Fosbøl,
Flemming Schønning Rosenvinge,
Henrik Carl Schønheyder,
Lars Køber,
Christian TorpPedersen,
Jannik HelwegLarsen,
Niels Tønder,
Claus Moser,
Henning Bundgaard
Publication year - 2018
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa1808312
Subject(s) - intravenous antibiotics , medicine , antibiotics , endocarditis , infective endocarditis , intravenous therapy , intravenous use , intravenous drug , intravenous infusions , anesthesia , surgery , microbiology and biotechnology , biology , virus , virology , viral disease
Patients with infective endocarditis on the left side of the heart are typically treated with intravenous antibiotic agents for up to 6 weeks. Whether a shift from intravenous to oral antibiotics once the patient is in stable condition would result in efficacy and safety similar to those with continued intravenous treatment is unknown.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom